All regulations
Nonrulemaking
FDA
FDA-2026-E-4540
Patent Term Application for YUVIWEL (navipegritide) Patent No. 11,224,661
Documents
2
Comments
0
Key Dates
Comment Period OpensApr 27, 2026
Documents
Keywords
CDER
Ascendis Pharma Growth Disorders AS
Alston and Bird LLP
Patent Term Application
for YUVIWEL (navipegritide)
Patent No 11224661
OPEN
Data from Regulations.gov